Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
30,284,111
-
Total 13F shares
-
15,819,144
-
Share change
-
+4,241,426
-
Total reported value
-
$1,114,418,058
-
Price per share
-
$70.54
-
Number of holders
-
78
-
Value change
-
+$300,498,502
-
Number of buys
-
66
-
Number of sells
-
9
Institutional Holders of Keros Therapeutics, Inc. - Common Stock, $0.0001 par value per share (KROS) as of Q4 2020
As of 31 Dec 2020 Keros Therapeutics, Inc. - Common Stock, $0.0001 par value per share (KROS) had 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 15,819,144 shares of stock of the company.
Largest 10 holders included FMR LLC, RA CAPITAL MANAGEMENT, L.P., ORBIMED ADVISORS LLC, Foresite Capital Management IV, LLC, BlackRock Inc., VR Adviser, LLC, VANGUARD GROUP INC, Consonance Capital Management LP, Nantahala Capital Management, LLC, and ALKEON CAPITAL MANAGEMENT LLC.
This table shows 79 institutional shareholders of the security as of 31 Dec 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.